In this study, an E2F1 ChIP-seq peak file from a prostate cancer cell-line LNCaP (16) was used to evaluate whether using 1 kb, instead of 10 kb, can improve the performance of Cistrome-GO for promoter-dominant TFs. Here, E2F1 is linked to prostate carcinoma.